Smoking Cessation

After pooling individual-level data from 112 cohort studies, researchers determined that more than 50% of cases of CVD can be attributed to five modifiable risk factors — BMI, systolic BP, non-HDL, current smoking and diabetes.

E-cigarette use increased overall and in those with a history of CVD who quit cigarette smoking from 2019 to 2020, according to a study published in JAMA Network Open.

Moderate to extreme chest pain reported 1 year after an MI may be indicative of increased mortality risk, according to a study published in the Journal of the American Heart Association.

Although a recent report from the CDC showed that cigarette smoking in 2021 is the lowest it has been since 1965, millions of people continue to smoke, with many struggling to quit with the current authorized treatments.

A 6- and 12-week course of cytisinicline were associated with higher rates of smoking cessation compared with placebo, according to results of the phase 3 ORCA-2 trial.

Quitting smoking after a cancer diagnosis can reduce CVD risk by 36% compared with continued smoking, yet 40% of patients who smoked opted to continue after a diagnosis, data from the Korean National Health Insurance Service show.

Patients with primary renal cell carcinoma who quit smoking after diagnosis had a 50% lower risk for death than those who continued to smoke, according to study results published in Journal of Clinical Oncology.

In this edition, tumor mutational burden linked to immunotherapy response; toripalimab regimen extends EFS in stage III NSCLC; phase 3 study designed for increasing trial diversity, and more.

Patients with non-small cell lung cancer who had stopped smoking before diagnosis had higher rates of survival after diagnosis, results of a retrospective cohort study showed.

More than three-fourths of newspaper articles on lung cancer screening published from 2010 to 2022 had a positive sentiment, according to study results published in American Journal of Roentgenology.